Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 8098-8108

  Xiao, Xiao ^a,b   Li, Juan ^a,b   Samulski, Richard Jude ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b CELL GENESYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS; ADOLESCENT; ANIMAL TISSUE; ARTICLE; EXPRESSION VECTOR; GENE TRANSFER; GENETIC TRANSDUCTION; IMMUNE RESPONSE; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE;

EID: 0029843596     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.8098-8108.1996     Document Type: Article

References (58)

1. Acsadi, G., A. Jani, J. Huard, K. Blaschuk, B. Massie, P. Holland, H. Lochmuller, and G. Karpati, 1994. Cultured human myohlasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Ther. 1:338-340.
2. Acsadi, G., A. Jani, B. Massie, M. Simoneau, P. Holland, K. Blaschuk, and G. Karpati. 1994. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3:579-584.
3. Acsadi, G., H. Lochmuller, A. Jani, J. Huard, B. Massie, S. Prescolt, M. Simoneau, B. J. Petrof, and G. Karpati. 1996. Dystrophin expression in muscle of mdx mice after adenovirus-mediated in vivo gene transfer. Hum. Gene Ther. 7:129-140.
4. Afione, S. A., C. K. Conrad, W. G. Kearns, S. Chunduru, R. Adams, T. Reynolds, W. B. Guggino, G. R. Cutting, B. J. Carter, and T. R. Flotte. 1996. In vivo model of adeno-associated virus vector persistence and rescue. J. Virol. 70:3235-3241.
5. Alexander, I. E., D. W. Russell, and A. D. Miller. 1994. DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J. Virol. 68:8282-8287.
6. Berns, K. I., and R. A. Bohenzky. 1987. Adeno-associated viruses: an update. Adv. Virus Res. 32:243-306. (Review.)
7. Berns, K. I., and R. M. Linden. 1995. The cryptic life style of adeno-associated virus. Bioessays 17:237-245.
8. Blau, H. M., and M, L. Springer. 1995. Muscle-mediated gene therapy. N. Engl. J. Med. 333:1554-1556. (Review.)
9. Dai, Y., M. Roman, R. K. Naviaux, and I. M. Verma. 1992. Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. USA 89:10892-10895.
10. Dai, Y., E. M. Schwarz, D. Gu, W. W. Zhang, N. Sarvetnick, and I. M. Verma. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92:1401-1405.
11. Davis, H. L., B. A. Demenelx, B. Quantin, J. Coulomb, and R. G. Whalen. 1993. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum. Gene Ther. 4:733-740.
12. DeMatteo, R. P., J. F. Markmann, K. F. Kozarsky, C. F. Barker, and S. E. Raper. 1996. Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion. Gene Ther. 3:4-12.
13. Department of Health and Human Services and National Institutes of Health and Recombinant DNA Advisory Committee. 1994. Minutes of meeting, 12-13 Sept. Hum. Gene Ther. 6:481-525.
14. Dunckley, M. G., D. J. Wells, F. S. Walsh, and G. Dickson. 1993. Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum. Mol. Genet. 2:717-723.
15. Engelhardt, J. F., L. Litiky, and J. M. Wilson. 1994. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum. Gene Ther. 5:1217-1229.
16. Fang, B., R. C. Eisensmith, H. Wang, M. A. Kay, R. E. Cross, C. N. Landen, G. Gordon, D. A. Bellinger, M. S. Read, P. C. Hu, et al. 1995. Gene therapy for hemophilia B: host immunosupprcssion prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum. Gene Ther. 6:1039-1044.
17. Ferrari, F. K., T. Samulski, T. Shenk, and R. J. Samulski. 1996. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70:3227-3234.
18. Fisher, K. J., G. P. Gao, M. D. Weitzman, R. DeMatteo, J. F. Burda, and J. M. Wilson. 1996. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70:520-532.
19. Flotte, T. R., S. A. Afione, C. Conrad, S. A. McGrath, R. Solow, H. Oka, P. L. Zeitlin, W. B. Guggino, and B. J. Carter. 1993. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 90:10613-10617.
20. Flotte, T. R., S. A. Afione, and P. L. Zeitlin. 1994. Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Resp. Cell Mol. Biol. 11:517-521.
21. Flotte, T. R., X. Barraza-Ortiz, R. Solow, S. A. Afione, B. J. Carter, and W. B. Guggino. 1995. An improved system for packaging rccombinant adeno-associated virus vectors capable of in vivo transduction. Gene Ther. 2:29-37.
22. Flotte, T. R., and B. J. Carter. 1995. Adeno-associated virus vectors for gene therapy. Gene Ther. 2:357-362.
23. Flotte, T. R., R. Solow, R. A. Owens, S. Afione, P. L. Zeitlin, and B. J. Carter. 1992. Gene expression from adeno-associated virus vectors in airway epithelial cells. Am. J. Resp. Cell Mol. Biol. 7:349-356.
24. Goldman, M. J., and J. M. Wilson. 1995. Expression of αvβ5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway. J. Virol. 69:5951-5958.
25. Goodman, S., X. Xiao, R. E. Donahue. A. Moulton, J. Miller, C. Walsh, N. S. Young, R. J. Samulski, and A. W. Nienhuis. 1994. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84:1492-1500. (Erratum, 85:862, 1995.)
26. Halben, C. L., I. E. Alexander, G. M. Wolgamot, and A. D. Miller. 1995. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J. Virol. 69:1473-1479.
27. Huard, J., H. Lochmuller, G. Acsadi, A. Jani, P. Holland, C. Guerin, B. Massie, and G. Karpati. 1995. Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants. Exp. Mol. Pathol. 62:131-143.
28. Kaplitt, M. G., P. Leone, R. J. Samulski, X. Xiao, D. W. Pfaff, K. L. O'Malley, and M. J. During. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8:148-154.
29. Kaplitt, M. G., X. Xiao, R. J. Samulski, J. Li, K. Ojamma, I. Klein, H. Makimura, M. J. Kaplitt, R. K. Strumpf, J. L. Breslow, and E. B. Diethrich. Long term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector. Ann. Thorac. Surg., in press.
30. Kay, M. A., A. X. Holterman. L. Meuse, A. Gown, H. D. Ochs, P. S. Linsley, and C. B. Wilson. 1995. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nature Genet. 11:191-197.
31. Kotin, R. M., and K. I. Berns. 1989. Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology 170:460-467.
32. Levy, M. Y., L. G. Barron, K. B. Meyer, and F. C. Szoka, Jr. 1996. Characterization of plasmid DNA transfer inlo mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood. Gene Ther. 3:201-211.
33. Lochmuller, H., A. Jani, J. Huard. S. Prescott, M. Simoneau, B. Massie, G. Karpati. and G. Acsadi. 1994. Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta El + delta E3) during multiple passages in 293 cells. Hum. Gene Thcrp. 5:1485-1491.
34. Lux, G., X. Xiao, and R. J. Samulski. Unpublished results.
35. McCown, T. J., X. Xiao, J. Li, G. R. Breese, and R. J. Samulski. 1996. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713:99-107.
36. McLaughlin, S. K., P. Collis, P. L. Hermonat, and N. Muzyczka. 1988. Adeno-associatcd virus general transduction vectors: analysis of proviral structures. J. Virol 62:1963-1973.
37. Miller, J. B., and F. M. Boyce. 1995. Gene therapy by and for muscle cells. Trends Genet. 11:163-165. (Review.)
38. Muzyczka, N. 1992. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158:97-129. (Review.)
39. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
40. Naviaux, R. K., and I. M. Verma. 1992. Retroviral vectors for persistent expression in vivo. Curr. Op. Biotechnol. 3:540-547. (Review.)
41. Podsakoff, G., K. K. Wong, Jr., and S. Chatterjee. 1994. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J. Virol. 68:5656-5666.
42. Ragot, T., N. Vincent, P. Chafey, E. Vigne, H. Gilgenkrantz, D. Couton, J. Cartaud, P. Briand, J. C. Kaplan, M. Perricaudet, et al. 1993. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature (London) 361:647-650.
43. Russell, D. W., I. E. Alexander, and A. D. Miller. 1995. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 92:5719-5723.
44. Russell, D. W., A. D. Miller, and I. E. Alexander. 1994. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. USA 91:8915-8919.
45. Samulski, R. J. 1993. Adeno-associated virus: integration at a specific chromosomal locus. Curr. Op. Genet. Dev. 3:74-80.
46. Samulski, R. J., L. S. Chang, and T. Shenk. 1989. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:3822-3828.
47. Sanes, J. R., J. L. Rubenstein, and J. F. Nicolas. 1986. Use of recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5:5133-5142.
48. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 2:545-550.
49. Vincent, N., T. Ragot, H. Gilgenkrantz, D. Couton, P. Chafey, A. Gregoire, P. Briand, J. C. Kaplan, A. Kahn, and M. Perricaudet. 1993. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet. 5:130-134.
50. Walsh, C. E., J. M. Liu, X. Xiao, N. S. Young, A. W. Nienhuis, and R. J. Samulski. 1992. Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 89:7257-7261.
51. Wolff, J. A., R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P. L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468.
52. Xiao, X., J. Li, and R. J. Samulski. Unpublished results.
53. Xiao, X., and R. J. Samulski. Unpublished observation.
54. Yang, Y., H. C. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with El-deleted recombinant adenoviruses. Immunity 1:433-442.
55. Yang, Y., Q. Li, H. C. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
56. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
57. Yang, Y., F. A. Nunes, K. Berencsi, E. Gonczol, J. F. Engelhardt, and J. M. Wilson. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7:362-369.
58. + CTLs in vivo. J. Immunol. 155:2564-2570.